Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
Clinical trial NCT03239561 · COMPLETED
Trial details
- NCT number
- NCT03239561
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2018-04-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.